Učitavanje...
Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics
Uncertainty exists regarding safety and efficacy of dual biological therapy (DBT) in inflammatory bowel disease. We present four cases of DBT in Crohn’s disease. Three patients had refractory disease non-responsive to biological monotherapy or combination therapy with immunomodulators. One patient h...
Spremljeno u:
| Izdano u: | BMJ Open Gastroenterol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254738/ https://ncbi.nlm.nih.gov/pubmed/30538822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2018-000243 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|